Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Clinical trial NCT06918431 · RECRUITING

Trial details

NCT number: NCT06918431
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Lymphoblastic Lymphoma

Start date: 2025-10-10
Primary completion: 2029-03-30
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.